Loading…
Adrenaline (epinephrine) microcrystal sublingual tablet formulation: enhanced absorption in a preclinical model
Objectives For anaphylaxis treatment in community settings, adrenaline (epinephrine) administration using an auto‐injector in the thigh is universally recommended. Despite this, many people at risk of anaphylaxis in community settings do not carry their prescribed auto‐injectors consistently and hes...
Saved in:
Published in: | Journal of pharmacy and pharmacology 2015-01, Vol.67 (1), p.20-25 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Objectives
For anaphylaxis treatment in community settings, adrenaline (epinephrine) administration using an auto‐injector in the thigh is universally recommended. Despite this, many people at risk of anaphylaxis in community settings do not carry their prescribed auto‐injectors consistently and hesitate to use them when anaphylaxis occurs.The objective of this research was to study the effect of a substantial reduction in adrenaline (Epi) particle size to a few micrometres (Epi microcrystals (Epi‐MC)) on enhancing adrenaline dissolution and increasing the rate and extent of sublingual absorption from a previously developed rapidly disintegrating sublingual tablet (RDST) formulation in a validated preclinical model.
Methods
The in‐vivo absorption of Epi‐MC 20 mg RDSTs and Epi 40 mg RDSTs was evaluated in rabbits. Epi 0.3 mg intramuscular (IM) injection in the thigh and placebo RDSTs were used as positive and negative controls, respectively.
Key findings
Epimean(standard deviation) area under the plasma concentration vs time curves up to 60 min and Cmax from Epi‐MC 20 mg and Epi 40 mg RDSTs did not differ significantly (P > 0.05) from Epi 0.3 mg IM injection. After adrenaline, regardless of route of administration, pharmacokinetic parameters were significantly higher (P |
---|---|
ISSN: | 0022-3573 2042-7158 |
DOI: | 10.1111/jphp.12312 |